ID
29929
Description
Study ID: 102123 Clinical Study ID: FFR102123 Study Title: A randomised double-blind placebo controlled parallel group multicentre long term study to evaluate the safety of once-daily, intranasal administration of GW685698X aqueous nasal spray 100mcg* for 52 weeks in adult and adolescent subjects with perennial allergic rhinitis. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate Trade Name: FLUTIDE, Allermist, Veramyst, FLUNASE, FLIXOTAIDE, FLUTAIDE, FLIXOVATE, Avamys; Veramyst, Avamys, Allermist Study Indication: Rhinitis, Allergic, Perennial This ODM-file contains Repeat Ophthalmic Examination.
Keywords
Versions (1)
- 4/27/18 4/27/18 - Sarah Riepenhausen
Copyright Holder
GlaxoSmithKline
Uploaded on
April 27, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Safety of once-daily administration of Fluticasone nasal spray in adults and adolescents with perennial allergic rhinitis GSK 102123
Repeat Opthalmic Examination
- StudyEvent: ODM
Similar models
Repeat Opthalmic Examination
- StudyEvent: ODM
C0205341 (UMLS CUI-2)
C0205341 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0205341 (UMLS CUI [1,2])
C0200149 (UMLS CUI [1,3])
C2826892 (UMLS CUI [1,2])
C1704292 (UMLS CUI [2,1])
C0029146 (UMLS CUI [2,2])
C0459875 (UMLS CUI [1,2])
C0010040 (UMLS CUI [1,2])
C0014259 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,2])
C0439792 (UMLS CUI [1,2])